Michelle Davis
Family · Riverton, UTNPI 1568075604
Payments from drug & device makers
Across 148 payments — averaging $29.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Sanofi$782
- GSK$493
- Genentech USA, Inc.$460
- Amgen$415
- Regeneron Healthcare Solutions, Inc.$363
- plus $918 from 15 others
What the payments were for
- Food & beverage$4,39799%
- Education$421%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 31 | $1,008 |
| Sanofi | 32 | $782 |
| GSK | 15 | $493 |
| Genentech USA, Inc. | 9 | $460 |
| Amgen | 11 | $415 |
| Regeneron Healthcare Solutions, Inc. | 10 | $363 |
| Incyte Corporation | 7 | $194 |
| Novartis | 8 | $151 |
| Organon | 3 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $84 |
| Blueprint Medicines Corporation | 1 | $75 |
| Biocryst US Sales Co., LLC | 3 | $63 |
| Kaleo, Inc. | 2 | $34 |
| Boehringer Ingelheim | 2 | $33 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $32 |
| Cycle Pharmaceuticals Inc | 2 | $27 |
| Ionis Pharmaceuticals, Inc. | 1 | $23 |
| Abbott | 1 | $20 |
| Optinose US, Inc. | 1 | $17 |
| Pharming Healthcare, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,439 in reported general payments places this provider in the 90th percentile of 1,460 family providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 18 | $372 |
| Azelastine Hcl | 16 | $318 |
| Montelukast Sodium | 11 | $235 |
Paid to pharmacies, not to this prescriber.
Other family in Riverton
- Riley WorthSandy$1.1M
- Katrina BawdenSalt Lake City$446K
- Cortnee RomanSalt Lake City$374K
- Jared ThorleySalt Lake City$368K
- Stephanie GodfreyLindon$358K
- Mary SteinbackSalt Lake City$189K
- Shannon FordSouth Jordan$186K
- Jennalyn MayeuxSalt Lake City$151K
- Brett RawlinsKaysville$149K
- Shelby MillerSandy$140K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.